These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 22262513

  • 21. Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis.
    Salaffi F, Stancati A, Carotti M.
    Clin Rheumatol; 2002 Nov; 21(6):478-87. PubMed ID: 12447631
    [Abstract] [Full Text] [Related]

  • 22. Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice.
    Linde L, Sørensen J, Østergaard M, Hetland ML.
    J Rheumatol; 2013 Sep; 40(9):1479-86. PubMed ID: 23818719
    [Abstract] [Full Text] [Related]

  • 23. Rapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden.
    Gülfe A, Kristensen LE, Saxne T, Jacobsson LT, Petersson IF, Geborek P.
    Ann Rheum Dis; 2010 Feb; 69(2):352-7. PubMed ID: 19282310
    [Abstract] [Full Text] [Related]

  • 24. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
    Linde L, Sørensen J, Østergaard M, Hørslev-Petersen K, Hetland ML.
    J Rheumatol; 2010 Feb; 37(2):285-90. PubMed ID: 20080905
    [Abstract] [Full Text] [Related]

  • 25. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.
    Chotai S, Parker SL, Sivaganesan A, Godil SS, McGirt MJ, Devin CJ.
    Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977
    [Abstract] [Full Text] [Related]

  • 26. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
    Wolfe F, Michaud K, Li T, Katz RS.
    J Rheumatol; 2010 Feb; 37(2):296-304. PubMed ID: 20032098
    [Abstract] [Full Text] [Related]

  • 27. Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain.
    Søgaard R, Christensen FB, Videbaek TS, Bünger C, Christiansen T.
    Value Health; 2009 Jun; 12(4):606-12. PubMed ID: 19900258
    [Abstract] [Full Text] [Related]

  • 28. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
    Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC, REFLEX Trial Group.
    Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627
    [Abstract] [Full Text] [Related]

  • 29. A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years.
    Barton GR, Sach TH, Avery AJ, Jenkinson C, Doherty M, Whynes DK, Muir KR.
    Health Econ; 2008 Jul; 17(7):815-32. PubMed ID: 17893863
    [Abstract] [Full Text] [Related]

  • 30. Determination of minimum clinically important difference in pain, disability, and quality of life after extension of fusion for adjacent-segment disease.
    Parker SL, Mendenhall SK, Shau D, Adogwa O, Cheng JS, Anderson WN, Devin CJ, McGirt MJ.
    J Neurosurg Spine; 2012 Jan; 16(1):61-7. PubMed ID: 21962034
    [Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies.
    Kvamme MK, Lie E, Uhlig T, Moger TA, Kvien TK, Kristiansen IS.
    Rheumatology (Oxford); 2015 Jul; 54(7):1226-35. PubMed ID: 25573840
    [Abstract] [Full Text] [Related]

  • 32. How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
    Boonen A, van der Heijde D, Landewé R, van Tubergen A, Mielants H, Dougados M, van der Linden S.
    Ann Rheum Dis; 2007 Jun; 66(6):771-7. PubMed ID: 17213254
    [Abstract] [Full Text] [Related]

  • 33. Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D.
    Sørensen J, Linde L, Ostergaard M, Hetland ML.
    Value Health; 2012 Jun; 15(2):334-9. PubMed ID: 22433765
    [Abstract] [Full Text] [Related]

  • 34. The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis.
    Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Verstappen SM, Watson K, Symmons DP, British Society for Rheumatology Biologics Register Control Centre Consortium.
    Qual Life Res; 2009 Nov; 18(9):1195-205. PubMed ID: 19777373
    [Abstract] [Full Text] [Related]

  • 35. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
    Adams R, Walsh C, Veale D, Bresnihan B, FitzGerald O, Barry M.
    Pharmacoeconomics; 2010 Nov; 28(6):477-87. PubMed ID: 20465316
    [Abstract] [Full Text] [Related]

  • 36. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
    Harrison MJ, Lunt M, Verstappen SM, Watson KD, Bansback NJ, Symmons DP.
    Health Qual Life Outcomes; 2010 Feb 11; 8():21. PubMed ID: 20149253
    [Abstract] [Full Text] [Related]

  • 37. Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden.
    Wallman JK, Eriksson JK, Nilsson JÅ, Olofsson T, Kristensen LE, Neovius M, Geborek P.
    J Rheumatol; 2016 Jul 11; 43(7):1292-9. PubMed ID: 27252420
    [Abstract] [Full Text] [Related]

  • 38. Accurately measuring outcomes after surgery for adult Chiari I malformation: determining the most valid and responsive instruments.
    Godil SS, Parker SL, Zuckerman SL, Mendenhall SK, McGirt MJ.
    Neurosurgery; 2013 May 11; 72(5):820-7; discussion 827. PubMed ID: 23381490
    [Abstract] [Full Text] [Related]

  • 39. EQ-5D versus SF-12 in coronary patients: are they interchangeable?
    De Smedt D, Clays E, Annemans L, De Bacquer D.
    Value Health; 2014 May 11; 17(1):84-9. PubMed ID: 24438721
    [Abstract] [Full Text] [Related]

  • 40. Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort.
    Gaujoux-Viala C, Fautrel B, Guillemin F, Flipo RM, Bourgeois P, Rat AC.
    Rheumatology (Oxford); 2013 May 11; 52(5):832-8. PubMed ID: 23093721
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.